Chemical composition and antinociceptive effects of essential oil from aerial parts of Gundelia tournefortii L Asteraceae (Compositae) in rats
Purpose: To investigate the antinociceptive effect of the essential oil from the aerial parts of Gundelia. tournefortii (EOGT) in various experimental models
Methods: The essential oil from the aerial parts of Gundelia tournefortii was extracted using steam distillation method median lethal dose (LD50) of EOGT was evaluated using the method of Lorke. Antinociceptive effect of EOGT in rats was carried out using chemical (formalin and acetic acid) and thermal (hot-plate) nociceptive tests at doses of 10, 31.6, 100, 316 and 1000 mg/kg. The possible mechanism of action of EOGT was also examined.
Results: In acute toxicity test, LD50 for EOGT was 2500 mg/kg. EOGT at test doses (10, 31.6, 100, 316 and 1000 mg/kg, orally) significantly reduced pain response in all tests in a dose-dependent manner (p < 0.05). Glibenclamide (potassium channel sensitive to ATP antagonist) and yoimbina (α2 adrenergic receptor antagonist), partially antagonized the antinociceptive activity induced by EOGT. However, naloxone (opioid antagonist) and L-NAME (an inhibitor of nitric oxide synthase) did not reverse the antinociception produced by EOGT.
Conclusion: Essential oil from the aerial parts of G. tournefortii shows significant antinociceptive activity, which appeared to involve the participation of K+ channels sensitive to ATP and adrenergic receptors. These findings justify in part the traditional use of the plant in the treatment of various painful conditions.
Keywords: Antinociceptive, Opioid receptors, Adrenergic receptor, Essential oil, Gundelia tournefortii, Formalin test
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.